skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Gynecologic Oncology remover idioma: Inglês remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Complications of the Ileocolonic Continent Urinary Reservoir (Miami Pouch)
Complications of the Ileocolonic Continent Urinary Reservoir (Miami Pouch)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Complications of the Ileocolonic Continent Urinary Reservoir (Miami Pouch)

Penalver, Manuel ; Donato, Daniel ; Sevin, Bernd-Uwe ; Bloch, William E. ; Alvarez, Wilfredo J. ; Averette, Hervy

Gynecologic oncology, 1994-03, Vol.52 (3), p.360-364 [Periódico revisado por pares]

San Diego, CA: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix
Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix

Vaquer, S. ; Jordá, J. ; de la Osa, E.López ; de los Heros, J.Alvarez ; López-García, N. ; de Mon, M.Alvarez

Gynecologic oncology, 1990, Vol.36 (1), p.90-92 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)
Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)

Pothuri, B. ; Blank, S.V. ; Myers, T.K. ; Hines, J.F. ; Randall, L.M. ; O'Cearbhaill, R.E. ; Slomovitz, B.M. ; Eskander, R.N. ; Alvarez Secord, A. ; Coleman, R.L. ; Walker, J.L. ; Monk, B.J. ; Moore, K.N. ; O'Malley, D.M. ; Copeland, L.J. ; Herzog, T.J.

Gynecologic oncology, 2023-07, Vol.174, p.278-287 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Management of chemotherapy hypersensitivity reactions and desensitization: An SGO clinical practice statement
Management of chemotherapy hypersensitivity reactions and desensitization: An SGO clinical practice statement
Material Type:
Artigo 		Adicionar ao Meu Espaço

Management of chemotherapy hypersensitivity reactions and desensitization: An SGO clinical practice statement

Hall, T.R. ; MacDonald, J.E. ; Bylinowski, K.M. ; Alvarez, E.A. ; Hardesty, M.M. ; Smith, J.A.

Gynecologic oncology, 2023-10, Vol.177, p.180-185 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer

Arend, Rebecca C ; Londoño-Joshi, Angelina I ; Samant, Rajeev S ; Li, Yonghe ; Conner, Michael ; Hidalgo, Bertha ; Alvarez, Ronald D ; Landen, Charles N ; Straughn, J. Michael ; Buchsbaum, Donald J

Gynecologic oncology, 2014-07, Vol.134 (1), p.112-120 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study

Monk, Bradley J. ; Kauderer, James T. ; Moxley, Katherine M. ; Bonebrake, Albert J. ; Dewdney, Summer B. ; Secord, Angeles Alvarez ; Ueland, Frederick R. ; Johnston, Carolyn M. ; Aghajanian, Carol

Gynecologic oncology, 2018-12, Vol.151 (3), p.422-427 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Society of Gynecologic Oncology (SGO) 2021 meeting report: Scaling new heights with innovative cancer care
Society of Gynecologic Oncology (SGO) 2021 meeting report: Scaling new heights with innovative cancer care
Material Type:
Artigo 		Adicionar ao Meu Espaço

Society of Gynecologic Oncology (SGO) 2021 meeting report: Scaling new heights with innovative cancer care

Gray, Heidi J. ; Secord, Angeles Alvarez

Gynecologic oncology, 2021-10, Vol.163 (1), p.5-10 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

Chan, John K. ; Brady, William ; Monk, Bradley J. ; Brown, Jubilee ; Shahin, Mark S. ; Rose, Peter G. ; Kim, Jae-Hoon ; Secord, Angeles Alvarez ; Walker, Joan L. ; Gershenson, David M.

Gynecologic oncology, 2018-08, Vol.150 (2), p.247-252 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Oaknin, Ana ; Friedman, Claire F. ; Roman, Lynda D. ; D'Souza, Anishka ; Brana, Irene ; Bidard, François-Clement ; Goldman, Jonathan ; Alvarez, Edwin A. ; Boni, Valentina ; ElNaggar, Adam C. ; Passalacqua, Rodolfo ; Do, Khanh T.M. ; Santin, Alessandro D. ; Keyvanjah, Kiana ; Xu, Feng ; Eli, Lisa D. ; Lalani, Alshad S. ; Bryce, Richard P. ; Hyman, David M. ; Meric-Bernstam, Funda ; Solit, David B. ; Monk, Bradley J.

Gynecologic oncology, 2020-10, Vol.159 (1), p.150-156 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance
Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance

Minion, Lindsey E ; Coleman, Robert L ; Alvarez, Ronald D ; Herzog, Thomas J

Gynecologic oncology, 2016-02, Vol.140 (2), p.193-198 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1994  (15)
  2. 1994Até2000  (15)
  3. 2001Até2007  (40)
  4. 2008Até2015  (72)
  5. Após 2015  (54)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.